Aratana signs $37M licensing deal for pet cancer products
March 20, 2014 at 13:20 PM EDT
Aratana Therapeutics Inc. announced it has acquired the licensing rights to four products from Advaxis Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|